Echinacoside (0–100 μM) inhibited the signaling of one of the MAPK pathways, Raf/MEK/ERK, in non-small cell lung cancer (NSCLC), the activation of which is associated with tumorigenic diseases. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.